Shared compound evidence record
Published analytical document
Retatrutide (30mg) report
A crawlable context record for Janoshik task 80925. The stored public report image is embedded as served, and the SHA-256 value below fingerprints that repository asset.
Report transcription
- Laboratory
- Janoshik
- Task number
- 80925
- Sample label
- R30
- Batch shown
- JP20250821
- Testing ordered
- 16 September 2025
- Sample received
- 26 September 2025
- Analysis conducted
- 1 October 2025
- Stock relationship
- Not established
Results shown in the source
| Analyte | Measurement | Reported value(s) |
|---|---|---|
| Retatrutide | content | 33.46 mg |
| Retatrutide | purity | 99.676% |
Stored public asset
Repository report image

SHA-256: E8C9EA37822ED871189830B7347B59D5DB4490917ED2CDC770DBFE730608B2C0
Connected catalogue records
Shared compound evidence record
Retatrutide (20mg)
Shared compound evidence record
Retatrutide Starter Bundle
Product recordDocumentation pending
Connected compound evidence
CJC-1295 (no DAC) (10mg)
Connected compound evidence
CJC-1295 (no DAC) + Ipamorelin (10mg)
Connected compound evidence